Diana Mutz of the Annenberg School for Communication discusses early media focus on presidential campaigns.
Penn in the News
Penn geneticists are cited for their research on Kennedy's disease.
Frank Claus of Financial Services discusses a payment option for tuition.
Ilana Reisner of the School of Veterinary Medicine offers tips on helping animals who fear storms.
Roderic Eckenhoff of the School of Medicine discusses the science behind nerves.
Arthur Caplan of the School of Medicine discusses stem-cell legislature and the media's effect.
Christos Davatzikos of the School of Medicine discusses early Alzheimer's detection methods.
Richard Leventhal of Penn Museum and the School of Arts and Sciences says international alliances are they key to enriched museums.
Sherrill Davison of the School of Veterinary Medicine says there are many resources in place should avian flu become a reality.
Jack Guttentag of the Wharton School authors an op-ed on subprime mortgages.
Paul Rozin of the School of Arts and Sciences says portioning your meals can help combat obesity.
Justin Wolfers of the Wharton School is cited for his research on happiness.
Richard Ingersoll of the Graduate School of Education and the School of Arts and Sciences says the best teachers often have the fastest turnover.
Leonard Lodish of the Wharton School discusses how television advertising is changing.
Elijah Anderson of the School of Arts and Sciences says socio-economic issues in certain areas of Philadelphia lead to a climate of violence.
P.J. Brennan of the School of Medicine discusses methods used by hospitals to report information-.
Nancy Rothbard of the Wharton School discusses how morning moods affect work productivity.
Andrew Newberg of the School of Medicine says scientific findings are interpreted differently depending on individual religious and philosophical beliefs.
Dean Richard Gelles of the School of Social Policy and Practice discusses what could lead a mother to kill her children.
Yvonne Paterson of the School of Medicine says the FDA’s delay in approval of cancer vaccines is delaying treatment for patients.